Refine Search
(4)
(5)
(6)
(6)

Musculoskeletal Diseases

MSDs are affected by age, occupation, activity level, lifestyle and family history. According to 2016 Global Burden of Disease (GBD) study, musculoskeletal conditions were the second highest contributor to global disability, and lower back pain remained the single leading cause of disability since it was first measured in 1990.

Prosthetic joint infections - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Prosthetic joint infections - Pipeline Review, H1 2018’, provides an overview of the Prosthetic joint infections pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Psoriatic Arthritis - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2018’, provides an overview of the Psoriatic Arthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Psoria...

Gouty Arthritis (Gout) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gouty Arthritis (Gout) - Pipeline Review, H1 2018’, provides an overview of the Gouty Arthritis (Gout) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Muscular Dystrophy - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Muscular Dystrophy - Pipeline Review, H1 2018’, provides an overview of the Muscular Dystrophy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Muscular...

Osteoarthritis - Pipeline Review, H1 2018

  • $2,000
  • February 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2018’, provides an overview of the Osteoarthritis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteoarthritis, ...

Cachexia - Pipeline Review, H2 2017

  • $2,000
  • September 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cachexia - Pipeline Review, H2 2017’, provides an overview of the Cachexia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cachexia, complete with anal...